Non-viral precision T cell receptor replacement for personalized cell therapySusan P. Foy, Stefanie Mandl, James R. Heath et al.|Nature|2022Cited by 276
Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint InhibitorsAdam J. Schoenfeld, Kai He, Sylvia M. Lee et al.|Cancer Discovery|2024Cited by 108
Phase II Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1–Pretreated Metastatic Non–Small Cell Lung Cancer and Metastatic Cutaneous MelanomaSylvia M. Lee, Charles Lance Cowey|Clinical Cancer Research|2024Cited by 7